News for Cardinal Health, Inc. (C1AH34.SA)

BofA's Lutz raised Cardinal Health's target to $170, citing specialty growth momentum and a shrinking scale gap as key upside drivers.

**media[651597]**

Cardinal Health, listed under the ticker CAH, has announced its upcoming Investor Day, scheduled for June 12, beginning at 9 a.m. This event is designed to prov

On June 10, 2025, B of A Securities maintained its

Cardinal Health (CAH) has entered into a strategic distribution agreement with Citius Oncology, a division of Citius Pharmaceuticals, to facilitate the launch o

Cardinal Health's growth faces challenges from tariff risks, regulatory uncertainties, and competitive pressures. Learn more on CAH stock here.

Cardinal Health (CAH) has introduced an advanced multi-parameter, single-patient monitoring system in the U.S. market. The new Kendall DL Multi System facilitat

Summary On June 4, 2025, Cardinal Health Inc (CAH) announced the U.S. launch of its Kendall DLâ„¢ Multi System, a multi-parameter, single-patient use monitoring

Summary Points: Wells Fargo upgrades Cardinal Health to Overweight, citing strong industry conditions. Analysts predict a potential price target of $179

On June 3, 2025, Cardinal Health (CAH) experienced a noteworthy upgrade from Wells Fargo analyst Stephen Baxter. The investment analyst has raised the price tar

Cardinal Health (CAH) is taking center stage amid fluctuating market conditions, prompting investors to reassess their portfolios. As market unpredictability pe

President Donald Trump has addressed the nation from the White House, highlighting the United States' trade agreement with China. As these talks unfold, compani

We recently published a list of Billionaire Mason Hawkins’ 10 Mid-Cap Stocks with Huge Upside Potential. In this article, we are going to take a look at where Cardinal Health, Inc.

Billionaire Mason Hawkins is the founder and chairperson of Southeastern Asset Management.

Investment Highlights: Cardinal Health (CAH) raises its quarterly dividend by 1%, emphasizing its commitment to shareholder returns. The company revises

On May 5, 2025, Morgan Stanley analyst Erin Wright announced an updated stock price target for Cardinal Health (CAH), raising it from $142.00 to $166.00. This a

Morgan Stanley has upped its price target for Cardinal Health (CAH) from $142 to $166, maintaining an Overweight rating on the stock. According to the firm's an

Cardinal Health (CAH) received a positive outlook from UBS analyst Kevin Caliendo on May 2, 2025. The analyst maintained a \

Cardinal Health Inc. (NYSE:CAH) on Thursday reported third-quarter 2025 adjusted EPS of $2.35, up 13% year over year, beating the consensus of $2.17. Sales remained flat at $54.9 billion, missing the consensus of $55.35 billion. Adjusted operating earnings increased 21% to $807 million. Third-quarter sales for the Pharmaceutical and Specialty Solutions segment remained unchanged at $50.6 billion. Third-quarter revenue increased by 20%, excluding the impact of the customer contract expiration, dr